| Issue Date | Title | Author(s) |
| 2012-06-01 | The malaria digestive vacuole | Wunderlich, J; Rohrbach, P; Dalton, JP |
| 2007-11-29 | Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds | Skinner-Adams, TS; Lowther, J; Teuscher, F; Stack, CM; Grembecka, J; Mucha, A; Kafarski, P; Trenholme, KR; Dalton, JP; Gardiner, DL |
| 2009-05-25 | Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica. | Miller, CMD; Smith, NC; Ikin, RJ; Boulter, NR; Dalton, JP; Donnelly, S |
| 2011-12-19 | The phylogeny, structure and function of trematode cysteine proteases, with particular emphasis on the Fasciola hepatica cathepsin L family | Stack, C; Dalton, JP; Robinson, MW |
| 2012-09-28 | X-ray crystal structure and specificity of the plasmodium falciparum malaria aminopeptidase PfM18AAP | Sivaraman, KK; Oellig, CA; Huynh, K; Atkinson, SC; Poreba, M; Perugini, MA; Trenholme, KR; Gardiner, DL; Salvesen, G; Drag, M; Dalton, JP; Whisstock, JC; McGowan, S |
| 2014-01-21 | Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity | El Ridi, R; Tallima, H; Selim, S; Donnelly, S; Cotton, S; Santana, BG; Dalton, JP |
| 2013-08-29 | Trematode Cysteine Endopeptidases | Robinson, MW; Brindley, PJ; McKerrow, JH; Dalton, JP |
| 2012-06-01 | The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria | Skinner-Adams, TS; Peatey, CL; Anderson, K; Trenholme, KR; Krige, D; Brown, CL; Stack, C; Nsangou, DMM; Mathews, RT; Thivierge, K; Dalton, JP; Gardiner, DL |
| 2013-01-01 | Helminth defence molecules-immunomodulators designed by parasites! | Robinson, MW; Donnelly, S; Dalton, JP |
| 2014-01-01 | Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases | El Ridi, R; Tallima, H; Dalton, JP; Donnelly, S |
